Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
3
×
boston blog main
boston top stories
clinical trials
fda
life sciences
national blog main
deals
investing
480 biomedical
arsenal medical
biofourmis
biotech ipos
biovotion
bob langer
chronic rhinosinusitis
chugai pharmaceutical
covid-19
drug delivery
dyne therapeutics
edbi
gaido health
genzyme
george whitesides
inflammation
ipo
keros therapeutics
kuldeep singh rajput
lyra therapeutics
massmutual ventures
medical device
medical devices
metacrine
mometasone furorate
myotonic dystrophy type 1
national top stories
nonalcoholic steatohepatitis
north bridge venture partners
novartis
What
million
raised
3
×
therapeutics
3
×
company
developing
ipo
treat
analytics
biofourmis
biotech
brings
data
debut
devices
digital
disorders
drug
dyne
dyne’s
employs
genetic
globally
hauls
help
late
lyra
markets
medicines
muscle
muscular
new
nose
noses
patients
persistently
preclinical
public
raises
rare
runny
Language
unset
Current search:
raised
×
boston
×
therapeutics
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses